SCHEMBL19911532

SCHEMBL19911532

CCCn1nnc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 6/20 0.57
SLC9A1 P19634 2/20 0.53
ALDH1A1 P00352 3/20 0.45
MGAM O43451 1/20 0.45
AMY1A P0DUB6 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
ATM Q13315 1/20 0.45
CNR1 P21554 2/20 0.44
CNR2 P34972 2/20 0.44
MAPT P10636 1/20 0.44
CYP1A2 P05177 1/20 0.44
ACHE P22303 1/20 0.44
NSD2 O96028 1/20 0.44
PKM P14618 2/20 0.43
GLS O94925 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19911531 0.92 HCAR3 (0.59) HCAR3SLC9A1ALDH1A1MGAMAMY1A
SCHEMBL19911553 0.89 SLC9A1 (0.53) HCAR3SLC9A1ALDH1A1MGAMAMY1A
SCHEMBL19911535 0.88 HCAR3 (0.55) HCAR3SLC9A1ALDH1A1MGAMAMY1A
SCHEMBL19911541 0.83 HCAR3 (0.46) HCAR3SLC9A1ALDH1A1MGAMAMY1A
SCHEMBL19911537 0.82 ALDH1A1 (0.47) ALDH1A1MGAMAMY1AGAASI
SCHEMBL30089555 0.82 ALDH1A1 (0.58) ALDH1A1GAACNR1CNR2MAPT
SCHEMBL28844023 0.82 ALDH1A1 (0.58) ALDH1A1GAACNR1CNR2MAPT
SCHEMBL19911547 0.82 ALDH1A1 (0.44) HCAR3ALDH1A1MGAMAMY1AGAA
SCHEMBL3474345 0.82 ALDH1A1 (0.44) HCAR3ALDH1A1MGAMAMY1AGAA
SCHEMBL19911556 0.81 SLC9A1 (0.55) HCAR3SLC9A1ALDH1A1MGAMAMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109776522-B Substituted heteroaryl compounds, compositions and uses thereof 广东东阳光药业有限公司 2020-12-29 CN disclosed
US-10683297-B2 Substituted heteroaryl compounds and methods of use CALITOR SCIENCES, LLC (US) 2020-06-16 US disclosed
US-20190152977-A1 SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE Northern Industrial Area, (CN) 2019-05-23 US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152977-A1 SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE PRKACA, PRKDC, PRKACB HCAR3 2296/4885SLC9A1 3880/4885ALDH1A1 4070/4885
US-10683297-B2 Substituted heteroaryl compounds and methods of use PRKACA, PRKDC, PRKACB HCAR3 2296/4885SLC9A1 3880/4885ALDH1A1 4070/4885
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery BPTF, BRD4, KCNN2 HCAR3 4636/4885SLC9A1 341/4885ALDH1A1 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.